Zain Khalpey/LinkedIn
Dec 19, 2025, 09:24
Zain Khalpey on A New Study Linking Low-dose Aspirin to Reduced Cancer Spread
Zain Khalpey, Adjunct Assistant Professor of Surgery at Columbia University Irving Medical Center, shared on LinkedIn:
”A paper in The New England Journal of Medicine outlines a mechanism by which low-dose aspirin may reduce cancer spread, particularly in colorectal cancer and in individuals with certain mutations or CHIP.
By lowering platelet activation and thromboxane A2 signaling, aspirin helps release T cells from immune suppression and supports antimetastatic immunity.
Follow Zain Khalpey for more on Ai and Healthcare.”
Read the full article in NEJM.
Article: Understanding How Aspirin Prevents Metastasis
Authors: Ruth E. Langley, John Burn
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 19, 2026, 15:34Kanishk Kumar: Wiskott-Aldrich Syndrome Pipeline Outlook Report 2026
-
Mar 19, 2026, 15:29Riten Kumar: Diagnosis and Management of Post-Thrombotic Sequelae Following Non-Extremity VTE in Children
-
Mar 19, 2026, 15:25Tom Rifai: Menopause as a Critical Window for Cardiometabolic Prevention
-
Mar 19, 2026, 15:16Glen Pyle: Association Between Premature Menopause and Coronary Heart Disease Risk
-
Mar 19, 2026, 15:14Georgiana Toma: Addressing Iron Deficiency Without Anemia
-
Mar 19, 2026, 15:01Erik Nelson: The Biomarker that Connects Heart, Brain, and DNA
-
Mar 18, 2026, 16:34Richard Buka: Exploring the COBRRA Trial in the Latest Episode of Don’t Just Read the Abstract
-
Mar 18, 2026, 16:22Heghine Khachatryan: Navigating the New Era of Hemophilia Gene Therapy
-
Mar 18, 2026, 16:21Georges Chahoud: Top Take-Home Messages from the AHA/ACC/Multisociety Acute PE Guideline